Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.

Journal of virology - 1 Mar 2001

Mertz J A, Mustafa F, Meyers S, Dudley J P

Abstract excerpt

Type B leukemogenic virus (TBLV) induces rapidly appearing T-cell tumors in mice. TBLV is highly related to mouse mammary tumor virus (MMTV) except that TBLV long terminal repeats (LTRs) have a deletion of negative regulatory elements and a triplication of sequences flanking the deletion. To determine if the LTR triplication represents a viral enhancer element, we inserted the triplication upstream and downstream...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Core Binding Factor Alpha 2 Subunit
Share to Enhancer Elements, Genetic
Share to Genes, Reporter

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Jurkat Cells

Share to Luciferases

Share to Retroviridae

Share to T-Lymphocytes

Share to Terminal Repeat Sequences

Source

Open in PubMed Open full text

Identifiers

PMID: 11160721
DOI: 10.1128/JVI.75.5.2174-2184.2001
PMCID: PMC114801

Genes

RUNX1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.PMID 11160721Read ↗

ALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancer.Semantic proximity Read ↗

Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.Semantic proximity Read ↗

Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3.Semantic proximity Read ↗

Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element.Semantic proximity Read ↗

Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.Semantic proximity Read ↗

Myb-induced chromatin remodeling at a dual enhancer/promoter element involves non-coding rna transcription and is disrupted by oncogenic mutations of v-myb.Semantic proximity Read ↗

A new leukemogenic retrovirus isolated from tumor cells derived from a radio-induced lymphoma of C57BL/6 mice: analysis of the env and LTR sequences.Semantic proximity Read ↗

Characterization of nuclear protein binding to a site in the long terminal repeat of a murine leukemia virus: comparison with the NFAT complex.Semantic proximity Read ↗

A single mutation in one of the CORE elements of Moloney murine leukemia virus reduced binding of a 42-kDa T lymphoma cell nuclear factor but did not affect lymphomagenesis.Semantic proximity Read ↗

The type B leukemogenic virus truncated superantigen is dispensable for T-cell lymphomagenesis.Semantic proximity Read ↗

The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis.Semantic proximity Read ↗

Identification of transcriptional regulatory activity within the 5' A-type monomer sequence of the mouse LINE-1 retroposon.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.